Works matching AU Wang, Zibing

Results: 27

Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitors

Published in:

Journal of Leukocyte Biology, 2025, v. 117, n. 5, p. 1, doi. 10.1093/jleuko/qiaf029

By:

Han, Lu;
Huang, Beibei;
Li, Linlin;
Xu, Benling;
Yang, Yonghao;
Zhao, Lingdi;
Wang, Zibing;
Zhang, Chaoji;
Gao, Quanli

Publication type:

Article

Immunotherapy-Related Cystitis: Case Report and Review of the Literature.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4321, doi. 10.2147/OTT.S321965

By:

Zhu, Liping;
Wang, Zhiqiang;
Stebbing, Justin;
Wang, Zibing;
Peng, Ling

Publication type:

Article

Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03605-1

By:

Sharma, Amit;
Ren, Xiubao;
Rosato, Antonio;
Sangiolo, Dario;
Wang, Zibing;
Tettamanti, Sarah;
Zhang, Yi;
Rettinger, Eva;
Fenix, Kevin Aaron;
Sommaggio, Roberta;
Cappuzzello, Elisa;
Schmidt-Wolf, Ingo G. H.

Publication type:

Article

Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 437, doi. 10.1007/s00262-022-03259-5

By:

Yuan, Shumin;
Peng, Ling;
Liu, Yuqing;
Till, Brian G.;
Yan, Xiang;
Zhang, Jie;
Zhu, Liping;
Wang, Huijuan;
Zhang, Shaokai;
Li, Hongle;
Gao, Quanli;
Wang, Zibing

Publication type:

Article

Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 385, doi. 10.1007/s00262-022-03254-w

By:

An, Mengchao;
Wang, Wenkang;
Zhang, Jie;
Till, Brian G.;
Zhao, Lingdi;
Huang, Hao;
Yang, Yonghao;
Li, Tiepeng;
Han, Lu;
Zhang, Xiaojie;
Qin, Peng;
Wang, Yunjian;
Zhang, Min;
Cui, Hong;
Gao, Quanli;
Wang, Zibing

Publication type:

Article

Thermodynamic Insights into Sustainable Aviation Fuel Synthesis via CO/CO 2 Hydrogenation.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 11, p. 1396, doi. 10.3390/catal13111396

By:

Liang, Bin;
Zhu, Qing;
Wang, Zibing;
Fan, Xiaoyu;
Yu, Xiao;
Cui, Yu;
Zhang, Chenxi;
Wei, Fei

Publication type:

Article

Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01513

By:

Wang, Zibing;
Liu, Xiaoli;
Till, Brian;
Sun, Miaomiao;
Li, Xiang;
Gao, Quanli

Publication type:

Article

Combination therapy using low‐dose anlotinib and immune checkpoint inhibitors for extensive‐stage small cell lung cancer.

Published in:

Cancer Innovation, 2024, v. 3, n. 6, p. 1, doi. 10.1002/cai2.155

By:

Li, Han;
Yuan, Shumin;
Wu, Han;
Wang, Yajie;
Ma, Yichen;
Tang, Xiance;
Fu, Xiaomin;
Zhao, Lingdi;
Xu, Benling;
Li, Tiepeng;
Qin, Peng;
You, Hongqin;
Han, Lu;
Wang, Zibing

Publication type:

Article

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1516524

By:

Pan, Shuxian;
Wang, Zibing

Publication type:

Article

Immune Responses against Disseminated Tumor Cells.

Published in:

Cancers, 2021, v. 13, n. 11, p. 2515, doi. 10.3390/cancers13112515

By:

Peng, Ling;
Zhang, Yongchang;
Wang, Zibing

Publication type:

Article

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.

Published in:

Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0237-6

By:

Zibing Wang;
Yuqing Liu;
Rui'e Li;
Yiman Shang;
Yong Zhang;
Lingdi Zhao;
Wei Li;
Yonghao Yang;
Xiaojie Zhang;
Tiejun Yang;
Changfu Nie;
Feng Han;
Ying Liu;
Suxia Luo;
Quanli Gao;
Yongping Song

Publication type:

Article

Deoxygenation of Chinese long-flame coal in low-temperature pyrolysis.

Published in:

Journal of Thermal Analysis & Calorimetry, 2018, v. 131, n. 3, p. 3025, doi. 10.1007/s10973-017-6753-y

By:

Wang, Zibing;
Kang, Running;
Wang, Chao;
Bin, Feng;
Wei, Xiaolin

Publication type:

Article

Aspirin, a potential GLUT1 inhibitor in a vascular endothelial cell line.

Published in:

Open Medicine, 2019, v. 14, n. 1, p. 552, doi. 10.1515/med-2019-0062

By:

Yabo Hu;
Xiaohan Lou;
Ruirui Wang;
Chanjun Sun;
Xiaomeng Liu;
Shuochuan Liu;
Zibing Wang;
Chen Ni

Publication type:

Article

Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e463, doi. 10.1093/oncolo/oyab068

By:

Yuan, Shumin;
Fu, Qiang;
Zhao, Lingdi;
Fu, Xiaomin;
Li, Tiepeng;
Han, Lu;
Qin, Peng;
Ren, Yingkun;
Huo, Mingke;
Li, Zhimeng;
Lu, Chaomin;
Yuan, Long;
Gao, Quanli;
Wang, Zibing

Publication type:

Article

Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency.

Published in:

Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.563622

By:

Yuan, Shumin;
Hu, Xiufeng;
Zhao, Yanqiu;
Wang, Zibing

Publication type:

Article

Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy.

Published in:

Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.563653

By:

Yuan, Shumin;
Liu, Yuqing;
Till, Brian;
Song, Yongping;
Wang, Zibing

Publication type:

Article

Unveiling sulfur vacancy pairs as bright and stable color centers in monolayer WS<sub>2</sub>.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53880-4

By:

Sun, Huacong;
Yang, Qing;
Wang, Jianlin;
Ding, Mingchao;
Cheng, Mouyang;
Liao, Lei;
Cai, Chen;
Chen, Zitao;
Huang, Xudan;
Wang, Zibing;
Xu, Zhi;
Wang, Wenlong;
Liu, Kaihui;
Liu, Lei;
Bai, Xuedong;
Chen, Ji;
Meng, Sheng;
Wang, Lifen

Publication type:

Article

The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-02597-5

By:

Fu, Xiaomin;
Li, Fanghui;
You, Hongqin;
Xu, Benling;
Wang, Tingjie;
Qin, Peng;
Han, Lu;
Zhang, Yong;
Zhang, Fang;
Zhao, Lingdi;
Ma, Baozhen;
Shang, Yiman;
Yang, Yonghao;
Wang, Zibing;
Qu, Jinrong;
Gao, Quanli

Publication type:

Article

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.728253

By:

Yang, Yonghao;
Li, Jun;
Till, Brian G.;
Wang, Jun;
Zhang, Bicheng;
Wang, Hanping;
Huang, Hao;
Li, Tiepeng;
Gao, Quanli;
Li, Hongle;
Wang, Zibing

Publication type:

Article

Adjusting the dose of traditional drugs combined with immunotherapy: reshaping the immune microenvironment in lung cancer.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1256740

By:

Linlin Wang;
Changqi Du;
Bing Jiang;
Lin Chen;
Zibing Wang

Publication type:

Article

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.640447

By:

Zhang, Xiaojie;
Huang, Hao;
Han, Lu;
Li, Tiepeng;
Wang, Zibing;
Gao, Quanli

Publication type:

Article

Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.882172

By:

Hao Huang;
Ling Peng;
Bicheng Zhang;
Till, Brian G.;
Yonghao Yang;
Xiaojie Zhang;
Lingdi Zhao;
Xiaomin Fu;
Tiepeng Li;
Lu Han;
Peng Qin;
Lin Chen;
Xiang Yan;
Yang Liu;
Wenkang Wang;
Zhenlong Ye;
Hongle Li;
Quanli Gao;
Zibing Wang

Publication type:

Article

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

Published in:

Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.779248

By:

Lingdi Zhao;
Tiepeng Li;
Yongping Song;
Yonghao Yang;
Baozhen Ma;
Yong Zhang;
Yiman Shang;
Benling Xu;
Jindong Guo;
Peng Qin;
Lu Han;
Xiaomin Fu;
Hongwei Lin;
Liang Liu;
Xiubao Ren;
Zibing Wang;
Quanli Gao

Publication type:

Article

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.772450

By:

Xing, Wenqun;
Zhao, Lingdi;
Zheng, Yan;
Liu, Baoxing;
Liu, Xianben;
Li, Tiepeng;
Zhang, Yong;
Ma, Baozhen;
Yang, Yonghao;
Shang, Yiman;
Fu, Xiaomin;
Liang, Guanghui;
Yuan, Dongfeng;
Qu, Jinrong;
Chai, Xiaofei;
Zhang, He;
Wang, Zibing;
Lin, Hongwei;
Liu, Liang;
Ren, Xiubao

Publication type:

Article

Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell Carcinoma.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.728750

By:

Yang, Yonghao;
Huang, Hao;
Li, Tiepeng;
Gao, Quanli;
Song, Yongping;
Wang, Zibing

Publication type:

Article

Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy.

Published in:

Theranostics, 2022, v. 12, n. 2, p. 944, doi. 10.7150/thno.67572

By:

Yuxuan Xiong;
Zibing Wang;
Qiang Wang;
Qingyuan Deng;
Jitang Chen;
Jianshuang Wei;
Xiaoquan Yang;
Xiangliang Yang;
Zifu Li

Publication type:

Article

The inter-link of ageing, cancer and immunity: findings from real-world retrospective study.

Published in:

Immunity & Ageing, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12979-023-00399-9

By:

Fu, Xiaomin;
Qin, Peng;
Li, Fanghui;
Zhu, Huifang;
You, Hongqin;
Zhang, Yong;
Xu, Benling;
Li, Tiepeng;
Zhang, Fang;
Han, Lu;
Zhao, Lingdi;
Ma, Baozhen;
Wang, Zibing;
Gao, Quanli

Publication type:

Article